| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:735813 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FANCC mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10566 | 6480464 | Ethinyl Estradiol affects the expression of FANCC mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10566 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FANCC mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10566 | 6480464 | Ethinyl Estradiol results in increased expression of FANCC mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | ISO | RGD:735813 | 6480464 | Estradiol results in decreased expression of FANCC mRNA | CTD | PMID:16705744 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10566 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FANCC mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10566 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FANCC mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735813 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FANCC mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10566 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FANCC mRNA | CTD | PMID:17942748 |
| 5-fluorouracil | decreases expression | ISO | RGD:735813 | 6480464 | Fluorouracil results in decreased expression of FANCC mRNA | CTD | PMID:16557594 |
| aflatoxin B1 | decreases expression | ISO | RGD:735813 | 6480464 | Aflatoxin B1 results in decreased expression of FANCC mRNA | CTD | PMID:21641981 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FANCC mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:735813 | 6480464 | Benzo(a)pyrene results in decreased expression of FANCC mRNA | CTD | PMID:22316170 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:10566 | 6480464 | Mustard Gas results in decreased expression of FANCC mRNA | CTD | PMID:15674843 |
| calcitriol | decreases expression | ISO | RGD:735813 | 6480464 | Calcitriol results in decreased expression of FANCC mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:735813 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of FANCC mRNA | CTD | PMID:21592394 |
| carmustine | affects response to substance | ISO | RGD:735813 | 6480464 | FANCC mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| chlorambucil | increases response to substance | ISO | RGD:735813 | 6480464 | FANCC protein results in increased susceptibility to Chlorambucil | CTD | PMID:16243825 |
| cisplatin | decreases response to substance | ISO | RGD:735813 | 6480464 | FANCC protein results in decreased susceptibility to Cisplatin | CTD | PMID:21115814 |
| cisplatin | decreases expression | ISO | RGD:735813 | 6480464 | Cisplatin results in decreased expression of FANCC mRNA | CTD | PMID:19561079 PMID:21532991 |
| cisplatin | increases response to substance | ISO | RGD:735813 | 6480464 | FANCC protein results in increased susceptibility to Cisplatin | CTD | PMID:16243825 |
| cisplatin | decreases expression | ISO | RGD:735813 | 6480464 | Cisplatin results in decreased expression of FANCC mRNA | CTD | PMID:21532991 |
| cypermethrin | increases expression | ISO | RGD:10566 | 6480464 | cypermethrin results in increased expression of FANCC mRNA | CTD | PMID:21142847 |
| diarsenic trioxide | increases expression | ISO | RGD:735813 | 6480464 | arsenic trioxide results in increased expression of FANCC mRNA | CTD | PMID:15070760 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of FANCC mRNA | CTD | PMID:21266533 |
| formaldehyde | increases response to substance | ISO | RGD:735813 | 6480464 | FANCC gene mutant form results in increased susceptibility to Formaldehyde | CTD | PMID:18056434 |
| genistein | decreases expression | ISO | RGD:735813 | 6480464 | Genistein results in decreased expression of FANCC mRNA | CTD | PMID:16705744 |
| lycopene | decreases expression | ISO | RGD:735813 | 6480464 | lycopene results in decreased expression of FANCC mRNA | CTD | PMID:16886892 |
| melphalan | increases response to substance | ISO | RGD:735813 | 6480464 | FANCC protein results in increased susceptibility to Melphalan | CTD | PMID:16243825 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of FANCC mRNA | CTD | PMID:23358140 |
| pirinixic acid | multiple interactions | ISO | RGD:735813 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FANCC mRNA | CTD | PMID:19710929 |
| rotenone | increases expression | ISO | RGD:735813 | 6480464 | Rotenone results in increased expression of FANCC mRNA | CTD | PMID:18191903 |
| tamoxifen | affects expression | ISO | RGD:10566 | 6480464 | Tamoxifen affects the expression of FANCC mRNA | CTD | PMID:17555576 |
| temozolomide | affects response to substance | ISO | RGD:735813 | 6480464 | FANCC mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| testosterone | multiple interactions | ISO | RGD:735813 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of FANCC mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:735813 | 6480464 | Testosterone results in decreased expression of FANCC mRNA | CTD | PMID:21592394 |
| testosterone enanthate | affects expression | ISO | RGD:735813 | 6480464 | testosterone enanthate affects the expression of FANCC mRNA | CTD | PMID:17440010 |